![]() |
市場調査レポート
商品コード
1433410
スーチャーアンカーデバイスの世界市場:2023-2030年Global Suture Anchor Devices Market 2023-2030 |
||||||
カスタマイズ可能
|
スーチャーアンカーデバイスの世界市場:2023-2030年 |
出版日: 2023年12月21日
発行: Orion Market Research
ページ情報: 英文 130 Pages
納期: 2~3営業日
|
世界のスーチャーアンカーデバイス市場は、予測期間(2024-2031年)にCAGR 4.3%で成長すると予測されています。市場成長の主な要因としては、整形外科的損傷の有病率の増加、靭帯やその他の筋骨格系構造に関連する問題に対処するための処置における使用の増加などが挙げられます。例えば、2021年12月に英国で発表されたWork-Related Musculoskeletal Disorders Statisticsによると、2020/21年には4,70,000人の労働者が仕事に関連した筋骨格系障害(新規または長期)に苦しんでいます。これは労働者10万人当たり1,420人に相当し、業務起因の全不健康の28.0%を占めています。
結紮タイプの中では、ノットレスのスーチャーアンカーサブセグメントが予測期間中に成長すると予測されています。このセグメントを牽引するのは、整形外科手術や軟部組織手術における低侵襲手技への動向の高まりで、ノットレスのスーチャーアンカーデバイスの需要に貢献しています。ノットレスのスーチャーアンカーは、手術中に結び目を作る必要がなく、手技を簡略化し、合併症のリスクを低減します。そのため、メーカー各社は市場の需要に応えるため、新製品の投入に力を入れています。2020年9月、医療技術事業を展開するSmith+Nephew plcは、HEALICOIL(TM)KNOTLESS Suture Anchorを発売し、腱板修復のための高度な治癒ソリューションの革命的な製品ラインを拡充しました。
世界のスーチャーアンカーデバイス市場は、北米(米国、カナダ)、欧州(英国、イタリア、スペイン、ドイツ、フランス、その他欧州地域)、アジア太平洋地域(インド、中国、日本、韓国、その他アジア地域)、世界のその他の地域(中東とアフリカ、ラテンアメリカ)を含む地域別にさらに細分化されています。なかでもアジア太平洋地域は、スーチャーアンカーデバイスに対する需要の高まり、老人人口の増加、低侵襲手術の増加、政府の支援策、有利なヘルスケア政策などにより、予測期間中に成長すると予測され、アジア太平洋地域のスーチャーアンカーデバイス市場を牽引しています。
北米は、スポーツ関連の怪我や加齢に伴う整形外科疾患の有病率の増加により、スーチャーアンカーデバイス市場で大きなシェアを占めると予想されています。Arthroscopy, Sports Medicine, and Rehabilitation誌で報告されているように、2022年に実施された調査では、選手の21%が膝の構造的損傷を経験しており、全体の損傷率は1,000試合露出あたり5.4人でした。年齢別に層別化すると、構造的膝損傷率は20歳未満の選手で最も高く(3.2/1,000GE)、次いで30歳未満(3.1/1,000GE)、25~29歳(3.0/1,000GE)、20~24歳(2.3/100GE)の順でした。1試合あたりのプレー時間別では、30分以上プレーしている人の割合が最も高く(3.9/1,000GE)、次いで20.0~29.9分(3.0/1,000GE)、10.0~19.9分(1.8/1,000GE)の順でした。このように、老年人口の増加は整形外科手術の増加と関連しており、この地域で調査された市場を後押ししています。
Global Suture Anchor Devices Market Size, Share & Trends Analysis Report by Material Type (Metallic Suture Anchor, Bio-Absorbable Suture Anchor, and Others), by Product (Absorbable, and Non-Absorbable), by Tying Type (Knotted Suture Anchors, and Knotless Suture Anchors), by End-Use (Hospitals, Clinics, and Ambulatory Surgical Centers), Forecast Period (2024-2031)
The global suture anchor devices market is anticipated to grow at a CAGR of 4.3% during the forecast period (2024-2031). Significant factors attributed to market growth includes increasing prevalence of orthopedic injuries, and growing use in procedures to address issues related to ligaments, and other musculoskeletal structures. For instance, iIn December 2021, Work-Related Musculoskeletal Disorders Statistics in Great Britain reported that 4,70,000 workers suffered from work-related musculoskeletal disorders (new or long-standing) in 2020/21. This represents 1,420 per 100,000 workers and thus accounts for 28.0% of all work-induced ill health.
The global suture anchor devices market is segmented on the by material type, product, tying type, and end-use. Based on the material type, the market is sub-segmented into metallic suture anchor, bio-absorbable suture anchor, and others. Others include polyetheretherketone (PEEK) suture anchor devices. Based on the product, the market is sub-segmented into absorbable, and non-absorbable. Based on the tying type, the market is sub-segmented into knotted suture anchors, and knotless suture anchors. Further, based on end-use, the market is sub-segmented into hospitals, clinics, and ambulatory surgical centers. Among the material type, the bio-absorbable suture anchor sub-segment is anticipated to hold a considerable share of the market, owing to the reducing the risk of adverse reactions, inflammation, or rejection, making them suitable for a wide range of patients.
Among the tying type, knotless suture anchors sub-segments expected to grow over the forecast period. The segment is driven by the growing trend towards minimally invasive procedures in orthopedic and soft tissue surgeries contributes to the demand for knotless suture anchor devices. Knotless suture anchors eliminate the need for tying knots during surgery, simplifying the procedure, and reducing the risk of complications, and are preferred by surgeons for their ease of use and potential for faster surgical times. Thus, the manufacturers are emphasizing on launching new products to cater to the demand in the market. In September 2020, Smith+Nephew plc, the medical technology business, launched the HEALICOIL™ KNOTLESS Suture Anchor, expanding its revolutionary line of advanced healing solutions for rotator cuff repair. This portfolio included the innovative REGENETEN™ Bioinductive Implant and novel REGENESORB™ Material. The open architecture design of the HEALICOIL KNOTLESS Suture Anchor coupled with REGENESORB Material was designed to facilitate a jump start in bone healing and formation.
The global suture anchor devices market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America). Among these, Asia-Pacific is anticipated to grow over the forecast period, owing to the growing demand for suture anchor devices, increasing geriatric population, growing number of minimally invasive procedures, supportive government initiatives, and favorable healthcare policies, driving the suture anchor devices market in the Asia-Pacific.
North America is expected to hold a prominent share in the suture anchor devices market, owing to the increasing prevalence of sports-related injuries and age-related orthopedic conditions. As reported in the Arthroscopy, Sports Medicine, and Rehabilitation journal, a study conducted in 2022 revealed that 21% of players experienced structural knee injuries, with an overall injury rate of 5.4 injuries per 1,000 game exposures. Stratified by age, structural knee injury rate was greatest in players less than 20 years old (3.2/1,000 GE) followed by less than 30 years old (3.1/1,000 GE), 25 to 29 years (3.0/1,000 GE), and 20 to 24 years (2.3/100 GE). Knee injury by minutes per game, the rate was greatest in those playing more than 30 minutes (3.9/1,000 GE), followed by 20.0 to 29.9 minutes (3.0/1,000 GE), and 10.0 to 19.9 minutes (1.8/1,000 GE). Thus, an increasing geriatric population is associated with an increase in orthopedic surgeries, thus boosting the market studied in the region. In April 2022, Statistics Canada published the article "A portrait of Canada's growing population aged 85 and older from the 2021 Census", that there were 7.3 million people aged 65 and older in the country. Furthermore, over the next 25 years (by 2046), the population aged 85 and above may get triple to almost 2.5 million people.
The major companies serving the suture anchor devices market include Arthrex, Inc., ConMed Corp., Johnson and Johnson (DePuy Synthes, Inc.), Smith & Nephew plc, and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in December 2022, Stryker Corp., launched the Citrefix™, a suture anchor system for foot and ankle surgical procedures. The new system used Citregen™, a bioresorbable material designed to mimic the chemistry and structure of native bone.